AMT-130 Gene Therapy Slows Huntington Disease Progression by 75 Percent
Experimental gene therapy AMT-130 slowed Huntington’s disease progression by 75 per cent over 36 months in a small clinical trial involving 29 patients, announced by uniQure and University College London scientists in September 2025, offering unprecedented hope for the fatal hereditary neurodegenerative disorder. A global clinical trial for a groundbreaking Huntington’s disease treatment has posted … Read more